Taysha Gene Therapies
TSHA
#7220
Rank
$0.38 B
Marketcap
$1.86
Share price
0.54%
Change (1 day)
10.06%
Change (1 year)

Taysha Gene Therapies (TSHA) - P/B ratio

P/B ratio as of December 2024 : 4.29

According to Taysha Gene Therapies's latest financial reports the company has a price-to-book ratio of 38.4462.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.

Taysha Gene Therapies - P/B ratio (from 2020 to 2024)

P/B ratio by year

Year P/B ratio Change
2024-12-314.27-3.31%
2023-12-314.42-97.03%
2022-12-311493064.46%
2021-12-314.7017.83%
2020-12-313.99

P/B ratio for similar companies or competitors

Company P/B ratio P/B ratio differencediff. Country
2.15-49.90%๐Ÿ‡บ๐Ÿ‡ธ USA